Clinical trials: Actinic Keratosis Olsen Grade I/II
Actinic Keratosis Olsen Grade I/II
Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
In this three-armed dose-finding trial 3 AK 3012 topical formulations shall be investigated with respect to safety and efficacy in order to identify the optimal concentration in the topical formulation.
- Trial name
- NCT01757613
- Testing
- AK 3012
- Where
- 9 sites in Germany
- Volunteers
- 150 people
- Sponsor
- Dolorgiet GmbH & Co. KG